Fast As A Whip, Pfizer Files Personalized Lung Cancer Drug Crizotinib
This article was originally published in The Pink Sheet Daily
Executive Summary
One of three Pfizer cancer drugs to be filed in 2011, crizotinib may help to turn the tide on pipeline setbacks. Axitinib and bosutinib filings are still to come.